Ragosa Mark bought KNSA
August 4, 2025 · Form 4 insider transaction
Ragosa Mark bought 18,889 shares of Kiniksa Pharmaceuticals International, plc at $22.89 per share, a transaction worth $432.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,889
Price
$22.89
Total value
$432.4K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateAugust 4, 2025
Filing dateAugust 6, 2025
Shares owned after45,898
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.